Jennifer Brown is a seasoned professional in corporate development and commercial strategy, currently serving as the Vice President of Corporate Development and Commercial Strategy at Zura Bio Limited (Nasdaq: ZURA). Previously, Jennifer held the position of Vice President of Commercial Strategy at Prelude Therapeutics and Vice President of Global Business Analytics & Commercial Operations at Turning Point Therapeutics. Jennifer's experience also includes serving as Senior Director of Global Business Analytics & Operations at Arena Pharmaceuticals, Inc., and as Principal at PharmaSpective LLC, showcasing a strong background in analytics and operational strategy within the pharmaceutical sector.
This person is not in any teams
This person is not in any offices
Zura Bio
1 followers
Zura Bio is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders. Currently, Zura Bio is developing three assets which have completed phase 1/1b studies and are Phase 2 ready. The company is developing a portfolio of therapeutic indications for tibulizumab (ZB-106), torudokimab (ZB-880), and ZB-168 with a goal of demonstrating their efficacy, safety, and dosing convenience in immune and inflammatory disorders. Zura Bio is headquartered in Henderson, NV with team members in the UK and USA.